A detailed history of Srs Capital Advisors, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 978 shares of EW stock, worth $73,721. This represents 0.01% of its overall portfolio holdings.

Number of Shares
978
Previous 879 11.26%
Holding current value
$73,721
Previous $81,000 20.99%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$59.7 - $93.78 $5,910 - $9,284
99 Added 11.26%
978 $64,000
Q2 2024

Aug 06, 2024

BUY
$84.3 - $94.31 $20,569 - $23,011
244 Added 38.43%
879 $81,000
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $725 - $955
10 Added 1.6%
635 $60,000
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $678 - $855
-11 Reduced 1.73%
625 $47,000
Q3 2023

Nov 14, 2023

BUY
$69.28 - $93.38 $32,838 - $44,262
474 Added 292.59%
636 $44,000
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $569 - $660
7 Added 4.52%
162 $15,000
Q1 2023

May 16, 2023

SELL
$74.26 - $84.51 $594 - $676
-8 Reduced 4.91%
155 $12,000
Q4 2022

Feb 24, 2023

SELL
$68.3 - $87.44 $21,173 - $27,106
-310 Reduced 65.54%
163 $12,000
Q3 2022

Nov 03, 2022

BUY
$82.37 - $107.29 $82 - $107
1 Added 0.21%
473 $39,000
Q2 2022

Aug 22, 2022

BUY
$86.5 - $128.27 $2,076 - $3,078
24 Added 5.36%
472 $45,000
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $2,752 - $3,465
-27 Reduced 5.68%
448 $53,000
Q3 2021

Nov 05, 2021

SELL
$102.91 - $122.75 $5,968 - $7,119
-58 Reduced 10.88%
475 $54,000
Q2 2021

Aug 02, 2021

SELL
$83.84 - $104.76 $586 - $733
-7 Reduced 1.3%
533 $55,000
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $10,750 - $13,990
-160 Reduced 22.86%
540 $43,000
Q2 2020

Aug 06, 2020

SELL
$57.54 - $76.95 $11,508 - $15,390
-200 Reduced 22.22%
700 $48,000
Q2 2019

Aug 08, 2019

SELL
$55.74 - $64.41 $39,073 - $45,151
-701 Reduced 43.79%
900 $166,000
Q4 2018

Feb 06, 2019

BUY
$46.41 - $56.94 $43,300 - $53,125
933 Added 139.67%
1,601 $245,000
Q3 2018

Nov 06, 2018

BUY
$45.7 - $58.03 $23,215 - $29,479
508 Added 317.5%
668 $116,000
Q2 2018

Aug 21, 2018

BUY
$42.45 - $51.3 $1,952 - $2,359
46 Added 40.35%
160 $23,000
Q1 2018

May 14, 2018

SELL
$37.19 - $47.45 $929 - $1,186
-25 Reduced 17.99%
114 $15,000
Q3 2017

Nov 15, 2017

BUY
$36.29 - $38.83 $5,044 - $5,397
139
139 $15,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.